The NLR and LMR Ratio in Newly Diagnosed MM Patients Treated Upfront With Novel Agents

Blood Cancer Journal - United States
doi 10.1038/s41408-017-0019-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Diffuse MRI Marrow Pattern Correlates With Increased Angiogenesis, Advanced Disease Features and Poor Prognosis in Newly Diagnosed Myeloma Treated With Novel Agents

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Toxicity of Upfront 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy in Newly Diagnosed Neuroblastoma Patients: A Retrospective Analysis

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2013English

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Turk Onkoloji Dergisi
Oncology
2019English

Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

New England Journal of Medicine
Medicine
2019English

Neutrophil to Lymphocyte Ratio as a Predictor of Left Ventricular Hypertrophy in Patients With Newly Diagnosed Hypertension

Journal of Hypertension and Management
2019English

Controversies in the Treatment of Elderly Patients With Newly Diagnosed Glioblastoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Serum Metallothionein in Newly Diagnosed Patients With Childhood Solid Tumours.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy